Puma Biotech (PBYI) – Globe Newswire
-
Knight Therapeutics Announces Health Canada Approval for NERLYNX® (Neratinib) to Treat HER2-Positive Metastatic Breast Cancer
-
Polyphor Announces Financial Results for the Full-Year 2020
-
Knight Therapeutics Announces Filling of Supplement to a New Drug Submission for NERLYNX® (neratinib) to Treat HER2-Positive Metastatic Breast Cancer
-
Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics
-
Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics
Back to PBYI Stock Lookup